Clinical Impact of SVGs of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced NSCLC

Clinical Impact of SVGs of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:

“Clinical impact of SVGs of oncogenes.

SVG – Somatic Genomic Variants

SVGs gene list – See slide below.”

Title: Clinical Impact of Somatic Genomic Variants of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced Non–Small Cell Lung Cancer

Authors: Deborah Di-Xin Zhou, et al.

Journal: JCO Precision Oncology, April 2025

Clinical Impact of SVGs of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced NSCLC

More posts featuring Katsuaki Maehara.